# An Observational Study of Valcyte (Valganciclovir) in D+/R- Liver Transplant Recipients

> **NCT02062294** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 14 (actual)

## Conditions studied

- Cytomegalovirus Infections

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02062294
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07-31
- **Primary completion:** 2011-09-30
- **Final completion:** 2011-09-30
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2017-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02062294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02062294, "An Observational Study of Valcyte (Valganciclovir) in D+/R- Liver Transplant Recipients". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02062294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*